Biotechnology Stocks II Performance Guide: Nurix Therapeutics, Inc. (NRIX)
NRIX has no dividends.
Table and Chart of NRIX Performance
See what a $1,000 investment in NRIX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| NRIX Returns | |
|---|---|
| Start Date | Aug-31-2020 |
| Start Price | $23.40 |
| End Date | Jul-26-2024 |
| End Price | $21.94 |
| # Prices | 48 |
| Min Date | Oct-31-2023 |
| Min Price | $5.59 |
| Max Date | Nov-30-2020 |
| Max Price | $42.62 |
| Total Return | -6.24% |
| Annualized Return | -1.60% |
| Current Value of $1,000 Purchase | $938 |
| Number Returns | 1,128 |
| Average Return | -25.65% |
| Number Profitable Returns | 243 |
| Percent Profitable Returns | 21.54% |
| Number Unprofitable Returns | 885 |
| Percent Unprofitable Returns | 78.46% |
| Profitable to Unprofitable Returns Ratio | 0.27 |
| NRIX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,355,226,000 |
| Beta | 2.224 | Price to Sales | 10.17 |
| Earnings per Share | $-2.9200 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 4.876 |
| PRICE DATA | |
| 52 Week High | $24.38 |
| 52 Week Low | $4.22 |
| Analyst Target Price | $27.91 |
| 50-Day Moving Average | $18.52 |
| 200-Day Moving Average | $12.08 |
| FINANCIAL DATA | |
| Revenue per Share | $1.101 |
| Revenue | $62,303,000 |
| Profit Margin | -264.8% |
| Return on Equity | -52.3% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
NRIX Compare Returns with S&P 500
NRIX Trendline Chart
NRIX Moving Average Chart
NRIX Stock Return Map - See Patterns of Gains and Losses
NRIX Stock Returns/Purchase Dates